Literature DB >> 21943566

The acne continuum: an age-based approach to therapy.

Sheila Fallon Friedlander1, Hilary E Baldwin, Anthony J Mancini, Albert C Yan, Lawrence F Eichenfield.   

Abstract

Acne vulgaris is classically considered a disease of adolescence. Although it most commonly occurs and has been best studied in that age group, it can develop at any time during childhood. It is important that health care practitioners recognize the manifestations of neonatal, infantile and childhood acne, as well as the differential diagnosis and best therapeutic approach in the younger child. Acneiform eruptions in infants and toddlers can occasionally be associated with scarring or with other significant disorders that may be life-threatening. In this article, the authors draw on their own clinical experience as well as the available literature to suggest an age-based approach to managing acne in children from the neonatal period through age 11 years.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21943566     DOI: 10.1016/j.sder.2011.07.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  3 in total

1.  Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.

Authors:  Angela Yen Moore; Edward L Lain; Amy McMichael; Leon Kircik; Andrea L Zaenglein; Adelaide A Hebert; Ayman Grada
Journal:  J Clin Aesthet Dermatol       Date:  2021-04-01

Review 2.  Synchronizing Pharmacotherapy in Acne with Review of Clinical Care.

Authors:  Sarvajnamurthy Aradhya Sacchidanand; Koushik Lahiri; Kiran Godse; Narendra Gajanan Patwardhan; Anil Ganjoo; Rajendra Kharkar; Varsha Narayanan; Dhammraj Borade; Lyndon D'souza
Journal:  Indian J Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.494

3.  Prediction of Antibacterial Peptides against Propionibacterium acnes from the Peptidomes of Achatina fulica Mucus Fractions.

Authors:  Suwapitch Chalongkulasak; Teerasak E-Kobon; Pramote Chumnanpuen
Journal:  Molecules       Date:  2022-03-31       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.